Asthmaniac will develop revenue from three channels: 1) Direct-to-Patient sales of asthma consultations; 2) Resell/License technology to HCO's and insurers including Private Insurance Companies, Telemedicine companies, Medicaid, Medicare, Indian Health Service, and Veterans Administration; and, 3) Clinical Research Revenue from grants to support scientific validation of the method.